These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 20329670)
21. [A prevalence study on hepatitis C infection in 4,055 healthy children of Beijing]. Chen M; Xia S Zhonghua Yu Fang Yi Xue Za Zhi; 1999 May; 33(3):158-9. PubMed ID: 11864475 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis B and C viral markers in patients with sickle cell disease in Ibadan, Nigeria. Fasola FA; Odaibo GN; Aken'Ova YA; Olaleye OD Afr J Med Med Sci; 2003 Sep; 32(3):293-5. PubMed ID: 15030091 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinical role of GBV-C infection after cardiac surgery in childhood: a study on 414 patients. Vogt M; Klostermann B; Braun S; Busch R; Hess J; Frösner G; Lang T J Infect; 2006 Jul; 53(1):43-8. PubMed ID: 16253334 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of antibodies to hepatitis C virus and other markers in Jamaica. King SD; Dodd RY; Haynes G; Wynter HH; Sullivan MT; Serjeant GR; Choo-Kang E; Michael E West Indian Med J; 1995 Jun; 44(2):55-7. PubMed ID: 7545339 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt. Kalil KA; Farghally HS; Hassanein KM; Abd-Elsayed AA; Hassanein FE East Mediterr Health J; 2010 Apr; 16(4):356-61. PubMed ID: 20795415 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370 [TBL] [Abstract][Full Text] [Related]
28. The declining risk of post-transfusion hepatitis C virus infection. Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736 [TBL] [Abstract][Full Text] [Related]
29. The association of infection and clinical severity in sickle cell anaemia patients. Neto JP; Lyra IM; Reis MG; Goncalves MS Trans R Soc Trop Med Hyg; 2011 Mar; 105(3):121-6. PubMed ID: 21216418 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey. Davaalkham D; Ojima T; Nymadawa P; Uehara R; Watanabe M; Oki I; Nakamura Y J Med Virol; 2006 Apr; 78(4):466-72. PubMed ID: 16482536 [TBL] [Abstract][Full Text] [Related]
31. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275 [TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of Hepatitis C viral antibodies in pregnancy in a tertiary health facility in Nigeria. Onakewhor JU; Okonofua FE Niger J Clin Pract; 2009 Mar; 12(1):65-73. PubMed ID: 19562925 [TBL] [Abstract][Full Text] [Related]
33. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641 [TBL] [Abstract][Full Text] [Related]
34. High prevalence of hepatitis C virus infection in the largest province of Pakistan. Idrees M; Lal A; Naseem M; Khalid M J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies to hepatitis C virus among normal blood donors and multi-transfused sickle-cell anaemia patients in Nigeria. Adewuyi JO Trop Doct; 1996 Jan; 26(1):29-30. PubMed ID: 8693560 [No Abstract] [Full Text] [Related]
36. Nocturnal enuresis: prevalence and risk factors among school-aged children with sickle-cell anaemia in a South-east Nigerian city. Eneh CI; Okafor HU; Ikefuna AN; Uwaezuoke SN Ital J Pediatr; 2015 Sep; 41():66. PubMed ID: 26416787 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of anti hepatitis C virus among the hospital populations in Jordan. Quadan A New Microbiol; 2002 Jul; 25(3):269-73. PubMed ID: 12173766 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus in sickle cell disease. Hassan M; Hasan S; Giday S; Alamgir L; Banks A; Frederick W; Smoot D; Castro O J Natl Med Assoc; 2003 Oct; 95(10):939-42. PubMed ID: 14620705 [TBL] [Abstract][Full Text] [Related]
39. Risk factors and clinical presentation of hepatitis C virus infection in Nigerians with chronic liver disease. Olokoba AB; Accama LA; Gashau W; Salawu FK Trop Doct; 2011 Jul; 41(3):146-7. PubMed ID: 21525077 [TBL] [Abstract][Full Text] [Related]
40. Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden. Ydreborg M; Söderström A; Håkanson A; Alsiö A; Arnholm B; Malmström P; Hellstrand K; Westin J; Lagging M Scand J Infect Dis; 2011 Jul; 43(6-7):522-7. PubMed ID: 21375426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]